P. R. Hedwall

520 total citations
26 papers, 410 citations indexed

About

P. R. Hedwall is a scholar working on Physiology, Biochemistry and Molecular Biology. According to data from OpenAlex, P. R. Hedwall has authored 26 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Physiology, 9 papers in Biochemistry and 5 papers in Molecular Biology. Recurrent topics in P. R. Hedwall's work include Eicosanoids and Hypertension Pharmacology (9 papers), Nitric Oxide and Endothelin Effects (6 papers) and Hormonal Regulation and Hypertension (4 papers). P. R. Hedwall is often cited by papers focused on Eicosanoids and Hypertension Pharmacology (9 papers), Nitric Oxide and Endothelin Effects (6 papers) and Hormonal Regulation and Hypertension (4 papers). P. R. Hedwall collaborates with scholars based in Switzerland and United States. P. R. Hedwall's co-authors include H. Brünner, Max Meier, A. Sallmann, R. Menassé, R. Jaques, L. Ma�tre, H. J. Bein, P. C. Waldmeier, L. Maître and Kent Hermsmeyer and has published in prestigious journals such as British Journal of Pharmacology, Cellular and Molecular Life Sciences and Pharmacology & Therapeutics.

In The Last Decade

P. R. Hedwall

24 papers receiving 352 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. R. Hedwall Switzerland 9 121 99 71 65 49 26 410
M. G. Bogaert Belgium 16 153 1.3× 88 0.9× 102 1.4× 91 1.4× 56 1.1× 34 533
Theodore Koppányi United States 10 57 0.5× 82 0.8× 59 0.8× 93 1.4× 33 0.7× 51 494
J. Salmon United Kingdom 8 98 0.8× 141 1.4× 124 1.7× 132 2.0× 32 0.7× 13 678
R. A. Clare United Kingdom 10 88 0.7× 143 1.4× 49 0.7× 57 0.9× 79 1.6× 17 606
R. Ceserani Italy 14 141 1.2× 102 1.0× 132 1.9× 31 0.5× 52 1.1× 52 530
Allan M. Burkman United States 14 61 0.5× 161 1.6× 139 2.0× 84 1.3× 65 1.3× 45 515
Louis Wj Australia 14 80 0.7× 133 1.3× 76 1.1× 150 2.3× 31 0.6× 29 547
Herwig Eggers Switzerland 10 176 1.5× 158 1.6× 59 0.8× 110 1.7× 63 1.3× 12 532
Murray Weiner United States 13 51 0.4× 77 0.8× 77 1.1× 52 0.8× 97 2.0× 52 578
John E. Baer United States 14 58 0.5× 298 3.0× 77 1.1× 61 0.9× 67 1.4× 24 723

Countries citing papers authored by P. R. Hedwall

Since Specialization
Citations

This map shows the geographic impact of P. R. Hedwall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. R. Hedwall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. R. Hedwall more than expected).

Fields of papers citing papers by P. R. Hedwall

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. R. Hedwall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. R. Hedwall. The network helps show where P. R. Hedwall may publish in the future.

Co-authorship network of co-authors of P. R. Hedwall

This figure shows the co-authorship network connecting the top 25 collaborators of P. R. Hedwall. A scholar is included among the top collaborators of P. R. Hedwall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. R. Hedwall. P. R. Hedwall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Baker, James, P. R. Hedwall, & Kent Hermsmeyer. (1992). Subcellular distribution of hydralazine in rat single vascular muscle cells. Cell Biology International Reports. 16(10). 1023–1039. 8 indexed citations
2.
Criscione, Leoluca, K. Eichenberger, P. R. Hedwall, & Karl Schmid. (1986). Hydralazine and Its Metabolites: In Vitro and In Vivo Activity in the Rat. Journal of Cardiovascular Pharmacology. 8(2). 420–427. 6 indexed citations
3.
4.
Menassé, R., et al.. (1978). Pharmacological Properties of Diclofenac Sodium and Its Metabolites. Scandinavian Journal of Rheumatology. 7(sup22). 5–16. 199 indexed citations
5.
Waldmeier, P. C., P. R. Hedwall, & L. Ma�tre. (1975). On the role of ?-methyldopamine in the antihypertensive effect of ?-methyldopa. Naunyn-Schmiedeberg s Archives of Pharmacology. 289(3). 303–314. 12 indexed citations
6.
Brünner, H., P. R. Hedwall, & Max Meier. (1971). General concepts in the use of?-blockers: The relative roles of specific and unspecific effects. Naunyn-Schmiedeberg s Archives of Pharmacology. 269(2-4). 219–231. 12 indexed citations
7.
Brünner, H. & P. R. Hedwall. (1970). Bedeutung der Nebennierenkatecholamine fr die reflektorische kardiovasculre Gegenregulation bei renal hypertonischen Ratten@@@Role of adrenal catecholamines in reflex cardiovascular adjustment in the renal hypertensive rat. Naunyn-Schmiedeberg s Archives of Pharmacology. 265(5). 387–396. 5 indexed citations
8.
Brünner, H. & P. R. Hedwall. (1970). Bedeutung der Nebennierenkatecholamine f�r die reflektorische kardiovascul�re Gegenregulation bei renal hypertonischen Ratten. Naunyn-Schmiedeberg s Archives of Pharmacology. 265(5). 387–396. 6 indexed citations
9.
Hedwall, P. R., et al.. (1970). Inhibition of Venoconstrictor Responses by Prostaglandin E1. Experimental Biology and Medicine. 135(3). 757–759. 8 indexed citations
10.
Wilhelm, M., P. R. Hedwall, & Max Meier. (1967). o-Allyloxy-phenoxy-propanolamine, eine neue Gruppe adrenergischer β-Rezeptoren-Blocker. Cellular and Molecular Life Sciences. 23(8). 651–652. 2 indexed citations
11.
Hedwall, P. R. & F.M. Dietrich. (1967). Production of antibodies against synthetic angiotensin II in various animal species. Cellular and Molecular Life Sciences. 23(11). 952–953. 1 indexed citations
12.
Brünner, H., P. R. Hedwall, L. Maître, & Max Meier. (1967). ANTIHYPERTENSIVE EFFECTS OF ALPHA‐METHYLATED CATECHOLAMINE ANALOGUES IN THE RAT*. British Journal of Pharmacology and Chemotherapy. 30(1). 108–122. 16 indexed citations
13.
Hedwall, P. R.. (1967). Versuche zur Beeinflussung der renalen Hypertonie durch Angiotensin-Antik�rper an der Ratte. Naunyn-Schmiedeberg s Archives of Pharmacology. 257(3). 282–282. 1 indexed citations
14.
Ma�tre, L., Manuel Meier, P. R. Hedwall, & Helmut Brünner. (1966). Ver�nderungen des Catecholamingehaltes im Herzen und Gehirn von Ratten nach Behandlung mit ?-methylierten Catecholaminanalogen. Naunyn-Schmiedeberg s Archives of Pharmacology. 255(1). 41–42. 2 indexed citations
15.
Brünner, H., P. R. Hedwall, L. Maître, & Max Meier. (1966). [Modification of the eserine pressor effect by propranolol].. PubMed. 254(1). 45–55. 1 indexed citations
16.
Brünner, H., P. R. Hedwall, L. Ma�tre, & Max Meier. (1966). Beeinflussung des pressorischen Eserin-Effekts durch Propranolol. Naunyn-Schmiedeberg s Archives of Pharmacology. 254(1). 45–55. 8 indexed citations
17.
Hedwall, P. R., et al.. (1965). Hemmung der Wirkung von Antihypertensiva an der renal hypertonischen Ratte. Naunyn-Schmiedeberg s Archives of Pharmacology. 251(2). 132–132. 4 indexed citations
18.
Brünner, H., P. R. Hedwall, & Max Meier. (1965). Inhibition of acute effects of hydralazine by an adrenergicβ-receptor blocking agent. Cellular and Molecular Life Sciences. 21(3). 136–137. 5 indexed citations
19.
Brünner, H., P. R. Hedwall, & Max Meier. (1965). Influence of an adrenergicβ-receptor blocking agent on the effect of various hypotensive agents in the hypertensive rat. Cellular and Molecular Life Sciences. 21(4). 231–232. 15 indexed citations
20.
Hedwall, P. R., et al.. (1965). [Effect of hydralazine and propranolol on the coronary circulation and oxygen consumption of the myocardium].. PubMed. 65(1). C36–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. G. Bogaert Breakdown of academic impact, for papers by Theodore Koppányi Breakdown of academic impact, for papers by J. Salmon Breakdown of academic impact, for papers by R. A. Clare Breakdown of academic impact, for papers by R. Ceserani Breakdown of academic impact, for papers by Allan M. Burkman Breakdown of academic impact, for papers by Louis Wj Breakdown of academic impact, for papers by Herwig Eggers Breakdown of academic impact, for papers by Murray Weiner Breakdown of academic impact, for papers by John E. Baer
Rankless by CCL
2026